title: Restoration of glutathione levels in vascular smooth muscle cells exposed to high glucose conditions.
abstract: Hyperglycemia-induced oxidative stress may play a key role in the pathogenesis of diabetic vascular disease. The purpose of this study was to determine the effects of glucose on levels of glutathione (a major intracellular antioxidant), the expression of gamma-glutamylcysteine synthetase (the rate-limiting enzyme in glutathione de novo synthesis), and DNA damage in human vascular smooth muscle cells in vitro. High glucose conditions and buthionine sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase, reduced intracellular glutathione levels in vascular smooth muscle cells. This reduction was accompanied by a decrease in the mRNA expression of both subunits of gamma-glutamylcysteine synthetase as well as an increase in DNA damage. In high glucose conditions, incubation of the vascular smooth muscle cells with alpha-lipoic acid and L-cystine restored glutathione levels. We suggest that the decrease in GSH levels seen in high glucose conditions is mediated by the availability of cysteine (rate-limiting substrate in de novo glutathione synthesis) and the gene expression of the gamma-glutamylcysteine synthetase enzyme. Glutathione depletion is associated with an increase in DNA damage, which can be reduced when glutathione levels are restored.
authors.affiliation: Department of Clinical Biochemistry, The Royal Group of Hospitals, Belfast, UK. l.powell@qub.ac.uk
authors.forename: L A
authors.initials: LA
authors.lastname: Powell
authors.forename: S M
authors.initials: SM
authors.lastname: Nally
authors.forename: D
authors.initials: D
authors.lastname: McMaster
authors.forename: M A
authors.initials: MA
authors.lastname: Catherwood
authors.forename: E R
authors.initials: ER
authors.lastname: Trimble
mesh_terms: D001011:Aorta / Q000166:cytology; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002478:Cells, Cultured; D003545:Cysteine / Q000494:pharmacology; D004249:DNA Damage / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology*; D005721:Glutamate-Cysteine Ligase / Q000235:genetics / Q000378:metabolism*; D005978:Glutathione / Q000378:metabolism*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D008063:Thioctic Acid / Q000494:pharmacology
chemical_list: D012333:RNA, Messenger; D019328:Buthionine Sulfoximine; D008063:Thioctic Acid; D005721:Glutamate-Cysteine Ligase; D005978:Glutathione; D005947:Glucose; D003545:Cysteine